{"id":"https://openalex.org/W2995437162","doi":"https://doi.org/10.1016/j.jval.2019.09.436","title":"PCN241 COSTS OF CYTOKINE RELEASE SYNDROME (CRS) AND NEUROLOGICAL EVENTS (NE) IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA RECEIVING LISOCABTAGENE MARALEUCEL (LISO-CEL) IN THE TRANSCEND NHL 001 CLINICAL TRIAL: A MICRO-COSTING STUDY FROM THE SPANISH NATIONAL HEALTH SYSTEM (NHS) PERSPECTIVE","display_name":"PCN241 COSTS OF CYTOKINE RELEASE SYNDROME (CRS) AND NEUROLOGICAL EVENTS (NE) IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA RECEIVING LISOCABTAGENE MARALEUCEL (LISO-CEL) IN THE TRANSCEND NHL 001 CLINICAL TRIAL: A MICRO-COSTING STUDY FROM THE SPANISH NATIONAL HEALTH SYSTEM (NHS) PERSPECTIVE","publication_year":2019,"publication_date":"2019-11-01","ids":{"openalex":"https://openalex.org/W2995437162","doi":"https://doi.org/10.1016/j.jval.2019.09.436","mag":"2995437162"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2019.09.436","doi":"https://doi.org/10.1016/j.jval.2019.09.436","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2019.09.436","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(19)32814-1/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.valueinhealthjournal.com/article/S1098-3015(19)32814-1/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039347595","display_name":"Mar\u00eda Presa","orcid":"https://orcid.org/0000-0001-5925-0619","observed_orcids":["https://orcid.org/0000-0001-5925-0619"]},"institutions":[{"id":"https://openalex.org/I4210165298","display_name":"Pharmacoeconomics and Health Outcomes Research Iberia (Spain)","ror":"https://ror.org/05sb05859","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210165298"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M. Presa","raw_affiliation_strings":["Pharmacoeconomics & Outcomes Research Iberia (PORIB), Pozuelo de Alarcon, M, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoeconomics & Outcomes Research Iberia (PORIB), Pozuelo de Alarcon, M, Spain","institution_ids":["https://openalex.org/I4210165298"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Varela","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Varela","raw_affiliation_strings":["Celgene, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene, Madrid, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069146288","display_name":"Itziar Oyag\u00fcez","orcid":"https://orcid.org/0000-0002-3047-6152","observed_orcids":["https://orcid.org/0000-0002-3047-6152"]},"institutions":[{"id":"https://openalex.org/I4210165298","display_name":"Pharmacoeconomics and Health Outcomes Research Iberia (Spain)","ror":"https://ror.org/05sb05859","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210165298"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"I. Oyag\u00fcez","raw_affiliation_strings":["Pharmacoeconomics & Outcomes Research Iberia (PORIB), Pozuelo de Alarc\u00f3n, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoeconomics & Outcomes Research Iberia (PORIB), Pozuelo de Alarc\u00f3n, Spain","institution_ids":["https://openalex.org/I4210165298"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2850,"currency":"USD","value_usd":2850},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":null,"first_page":"S482","last_page":"S482"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.7896000146865845,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.7896000146865845,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.14550000429153442,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.03220000118017197,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.9909999966621399},{"id":"https://openalex.org/keywords/neurological-events","display_name":"neurological events","score":0.9459999799728394},{"id":"https://openalex.org/keywords/liso-cel","display_name":"liso-cel","score":0.9390000104904175},{"id":"https://openalex.org/keywords/relapsed-refractory-b-cell-non-hodgkin-lymphoma","display_name":"relapsed/refractory B-cell non-Hodgkin lymphoma","score":0.9359999895095825},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8659999966621399},{"id":"https://openalex.org/keywords/anti-cd19-antibody","display_name":"anti-CD19","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cost-estimation","display_name":"cost estimation","score":0.527999997138977},{"id":"https://openalex.org/keywords/microcosting","display_name":"micro-costing","score":0.7710000276565552},{"id":"https://openalex.org/keywords/spanish-national-health-system","display_name":"Spanish National Health System","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8046572208404541},{"id":"https://openalex.org/C2780850621","wikidata":"https://www.wikidata.org/wiki/Q3961647","display_name":"Cytokine release syndrome","level":5,"score":0.6650339961051941},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.45386362075805664},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4486152231693268},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.44259461760520935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44073840975761414},{"id":"https://openalex.org/C2779788671","wikidata":"https://www.wikidata.org/wiki/Q998803","display_name":"Tumor lysis syndrome","level":3,"score":0.43925589323043823},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.42692604660987854},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.41621118783950806},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.41433221101760864},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.37529700994491577},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2172812521457672},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21381545066833496},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.17136850953102112},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2019.09.436","doi":"https://doi.org/10.1016/j.jval.2019.09.436","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2019.09.436","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(19)32814-1/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2019.09.436","doi":"https://doi.org/10.1016/j.jval.2019.09.436","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2019.09.436","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(19)32814-1/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2995437162.pdf","grobid_xml":"https://content.openalex.org/works/W2995437162.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2947732194","https://openalex.org/W4389219909","https://openalex.org/W4389229925","https://openalex.org/W4389244480","https://openalex.org/W3026038607","https://openalex.org/W3139382474","https://openalex.org/W3030085018","https://openalex.org/W2907979991","https://openalex.org/W4283520956","https://openalex.org/W4306850865"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2019-12-26T00:00:00"}